11 – 20 of 60
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Anti-ApoA-I IgG antibodies are not associated with carotid artery disease progression and first-time cardiovascular events in middle-aged individuals
(
- Contribution to journal › Article
-
Mark
Novel ABCA1 peptide agonists with antidiabetic action
(
- Contribution to journal › Article
-
Mark
ApoAI-derived peptide increases glucose tolerance and prevents formation of atherosclerosis in mice
(
- Contribution to journal › Article
-
Mark
Loss of ZnT8 function protects against diabetes by enhanced insulin secretion
(
- Contribution to journal › Article
- 2018
-
Mark
Site-specific glycations of apolipoprotein A-I lead to differentiated functional effects on lipid-binding and on glucose metabolism
(
- Contribution to journal › Article
-
Mark
High-efficient bacterial production of human ApoA-I amyloidogenic variants
(
- Contribution to journal › Article
- 2017
-
Mark
Structural determinants in ApoA-I amyloidogenic variants explain improved cholesterol metabolism despite low HDL levels
(
- Contribution to journal › Article
-
Mark
Plasma stem cell factor levels are associated with risk of cardiovascular disease and death
(
- Contribution to journal › Article
-
Mark
Synchrotron radiation circular dichroism spectroscopy reveals structural divergences in HDL-bound apoA-I variants
(
- Contribution to journal › Article
-
Mark
Apolipoprotein A-I attenuates LL-37-induced endothelial cell cytotoxicity
(
- Contribution to journal › Article